Startup Lightning Talks - 2022 MIT Health Science Technologies Conference The Future of Cell & Gene Therapies
This conference will explore new or improved therapeutic approaches for finding cures for diseases which traditionally have been difficult to treat. This includes technologies for optimizing treatments and monitoring efficacy based on insights into cell and tissue state, circuitry, behavior, function, and responsiveness in normal and disease states, biomarker detection, better methods to predict and track efficacy, and enhanced manufacturing capabilities.
Ingersoll Rand is seeking early stage technology to commercialize, with the aim of yielding more data connectivity and performance for productivity, efficiency, and sustainability improvements.
Investing in Science Based Startups
Multiply Labs